International Symposium on Radiopharmaceutical Sciences (Australia)

Two of our radiochemists represented the CIRC at the International Symposium on Radiopharmaceutical Sciences (iSRS) 2025. They actively contributed to the scientific programme, engaged with leaders in the field, and strengthened CIRC’s international network.

During the exhibition, they also presented two posters showcasing ongoing work within our radiochemistry team: “A Gallium-68 Radiolabelled NOTA-Conjugated Evans Blue Derivative: Optimization of the Synthesis and Purification Approach” and “First Development and Validation in Southeast Asia (Singapore) of an Automated Synthesis of an EB-Linked [177Lu] Somatostatin Receptor–Targeting Radiotracer Using Scintomics Under PIC/S GMP Compliance.” Their participation highlights CIRC’s commitment to advancing radiopharmaceutical science and fostering global research collaborations.